Quotient discloses underwritten public offering price
June 24, 2022 -- Commercial-stage diagnostics company Quotient recently disclosed the pricing of an underwritten public offering of 66,666,667 ordinary shares and ordinary share equivalents for aggregate gross proceeds of $20.0 million. Read More
QHSLab enters alliance with Medical License Factory
June 24, 2022 -- QHSLab is entering into a strategic alliance with Medical License Factory for its AllergiEnd allergy diagnostic test and allergen immunotherapy products, as well as clinical decision support digital health services. Read More
OpGen touts study on Unyvero pneumonia panel
June 24, 2022 -- OpGen is promoting a study showing that the company’s Unyvero hospitalized pneumonia panel detects potential pneumonia pathogens early, the results published June 22 in the European Journal of Clinical Microbiology & Infectious Diseases. Read More
Myriad, Epic partner for genetic testing integration
June 24, 2022 -- Myriad Genetics is partnering with Epic to integrate Myriad’s genetic testing line with Epic’s network of physicians and patients. Read More
ACLA praises bill to maintain lab services for seniors
June 23, 2022 -- The American Clinical Laboratory Association (ACLA) has applauded the recent introduction of the Saving Access to Laboratory Services Act (SALSA) in Congress to ensure that seniors maintain access to clinical laboratory tests and services in the face of pending Medicare cuts next year. Read More
Nanomix launches trial of eLab analyzer and panel
June 23, 2022 -- Nanomix has launched a trial in Spain to evaluate its eLab mobile immunoassay diagnostic system and S1 Panel assay for the detection of critical infections. Read More
Eurofins develops monkeypox PCR assay
June 23, 2022 -- Eurofins Technologies has developed a new multiplex real-time polymerase chain reaction (RT-PCR) assay for the detection of the monkeypox virus and its differentiation from other orthopoxviruses. Read More
Pictor receives CE Mark for COVID-19 test
June 23, 2022 -- Pictor has received Europe's CE Mark for its PictArray SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test. Read More
Illumina launches research test for HRD
June 22, 2022 -- Illumina on Wednesday announced the launch of a next-generation sequencing (NGS)-based research-use-only test for homologous recombination deficiency that it has developed with Merck. Read More
Fountain Health Insurance to cover Grail multicancer test
June 22, 2022 -- Grail’s multicancer early detection (MCED) blood test, Galleri, is being made available to Fountain Health Insurance customers at 100% coverage, the firms announced on Tuesday. Read More